Meyer Colin John
Officer at REATA PHARMACEUTICALS INC
- Sold, on record
- $26.4M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Aug 16, 2023
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- REATA PHARMACEUTICALS INCOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale REATA PHARMACEUTICALS INCUnusualMar 3 2023
Sold 93,922 shares at $86.72 ($8.1M)
Meyer Colin John, Chief Innovation Officer
Sold 52.4% of holdings ($15.5M position)85,227 shares leftFiling
- 2 Form 4 sale REATA PHARMACEUTICALS INCPlan not statedMar 7 +4 days
Sold 621 shares at $84.57 ($53k)
Meyer Colin John, Chief Innovation Officer
Sold 0.7% of holdings ($7.2M position)84,606 shares leftFiling
- 3 Form 144 notice REATA PHARMACEUTICALS INCNoticeMay 15 +69 days
Filed to sell 5,608 shares ($476k)
Meyer Colin John, Officer
No 10b5-1 plan0.1x usual sizeFiling
- 4 Form 144 notice REATA PHARMACEUTICALS INCNoticeMay 16 +1 day
Filed to sell 625 shares ($51k)
Meyer Colin John, Officer
No 10b5-1 plan0x usual sizeFiling
- 5 Form 4 sale REATA PHARMACEUTICALS INCNo planMay 16 same day
Sold 6,233 shares at $84.56 ($527k)
Meyer Colin John, Chief Innovation Officer
No 10b5-1 planSold 7.4% of holdings ($7.2M position)78,373 shares left0.1x usual sizeFollows a Form 144Filing
- 6 Form 144 notice REATA PHARMACEUTICALS INCNoticeAug 15 +91 days
Filed to sell 2,144 shares ($362k)
Meyer Colin John, Officer
No 10b5-1 plan0.3x usual sizeFiling
- 7 Form 144 notice REATA PHARMACEUTICALS INCNoticeAug 16 +1 day
Filed to sell 596 shares ($101k)
Meyer Colin John, Officer
No 10b5-1 plan0.1x usual sizeFiling
- 8 Form 4 sale REATA PHARMACEUTICALS INCNo planAug 16 same day
Sold 2,740 shares at $169.00 ($463k)
Meyer Colin John, Chief Innovation Officer
No 10b5-1 planSold 3.2% of holdings ($14.3M position)81,633 shares left0.4x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (11)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | REATA PHARMACEUTICALS INC | Chief Innovation Officer | Form 4 sale | 2,740 | $463k | 3.2% | No plan | SEC |
| Aug 16, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 596 | $101k | Notice | SEC | |
| Aug 15, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 2,144 | $362k | Notice | SEC | |
| May 16, 2023 | REATA PHARMACEUTICALS INC | Chief Innovation Officer | Form 4 sale | 6,233 | $527k | 7.4% | No plan | SEC |
| May 16, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 625 | $51k | Notice | SEC | |
| May 15, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 5,608 | $476k | Notice | SEC | |
| Mar 7, 2023 | REATA PHARMACEUTICALS INC | Chief Innovation Officer | Form 4 sale | 621 | $53k | 0.7% | Plan not stated | SEC |
| Mar 3, 2023 | REATA PHARMACEUTICALS INC | Chief Innovation Officer | Form 4 sale | 93,922 | $8.1M | 52.4% | Unusual | SEC |
| Jun 15, 2021 | REATA PHARMACEUTICALS INC | Chief Research Officer | Form 4 sale | 60,000 | $8.6M | 77.9% | Unusual | SEC |
| Nov 17, 2020 | REATA PHARMACEUTICALS INC | Chief Research Officer | Form 4 sale | 25,000 | $4.2M | 25.8% | Unusual | SEC |
| Nov 9, 2020 | REATA PHARMACEUTICALS INC | Chief Research Officer | Form 4 sale | 25,000 | $4.4M | 25.8% | Unusual | SEC |